IDEAL study: A real‐world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX‐FP) in patients with haemophilia B in Italy.

Autor: Tagliaferri, Annarita1 (AUTHOR), Molinari, Angelo Claudio2 (AUTHOR), Peyvandi, Flora3 (AUTHOR), Coppola, Antonio1 (AUTHOR), Demartis, Francesco4 (AUTHOR), Biasoli, Chiara5 (AUTHOR), Borchiellini, Alessandra6 (AUTHOR), Cultrera, Dorina7 (AUTHOR), De Cristofaro, Raimondo8 (AUTHOR), Daniele, Filomena9 (AUTHOR), Giordano, Paola10 (AUTHOR), Marchesini, Emanuela11 (AUTHOR), Margaglione, Maurizio12 (AUTHOR), Marino, Renato13 (AUTHOR), Pollio, Berardino14 (AUTHOR), Radossi, Paolo15 (AUTHOR), Santoro, Cristina16 (AUTHOR), Santoro, Rita Carlotta17 (AUTHOR), Siragusa, Sergio18 (AUTHOR), Sottilotta, Gianluca19 (AUTHOR)
Zdroj: Haemophilia. Jan2023, Vol. 29 Issue 1, p135-144. 10p. 4 Diagrams, 1 Chart, 2 Graphs.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje